A research study of a new medicine NNC0363-1063 in healthy participants and participants with type 1 diabetes
This research study is investigating a new medication, NNC0363-1063, in people who have type 1 diabetes, as well as in healthy volunteers. This is an early-stage study, meaning it's the first time this new medicine will be given to people. The main goal is to understand how the medicine behaves in the human body, such as how it's absorbed, distributed, and removed, and to check for any early signs of side effects. This kind of study is crucial for determining if a new medicine is safe enough to be tested in larger groups of people later on. By taking part, you could contribute to the development of potential new treatments for type 1 diabetes.
At a glance
What is this study about?
This research study is focused on a new medicine called NNC0363-1063. We're looking for both people who have type 1 diabetes and healthy volunteers to take part. The main aim is to understand how this new medicine works in the human body and to see if it's safe. Think of it like taking a brand-new car for its very first test drive – we want to see how it performs and if there are any immediate concerns. This is a very early stage of research, often called a 'Phase 1' study.
During this study, researchers will carefully monitor how the new medicine is absorbed into your body, how it travels around, and how your body eventually gets rid of it. They will also be looking out for any side effects, both expected and unexpected. Because this is the first time humans will be given this medicine, safety is the top priority.
Studies like this are really important because they are the first step in developing new treatments. If this medicine proves to be safe and shows promise in this early phase, it could move on to further, larger studies. Ultimately, the goal is to find new and better ways to manage type 1 diabetes and improve the lives of people living with it. Your participation could help make a difference for many people in the future.
Key takeaways
- It's a study of a brand-new medicine for type 1 diabetes.
- This is the very first time the medicine is given to humans.
- The main goals are to check for safety and how the medicine works in the body.
- Both people with type 1 diabetes and healthy adults can take part.
- Participation involves regular visits and health checks.
Who may be eligible?
To join this study, you need to be an adult, aged 18 years or older. There is no upper age limit, meaning older adults can also take part.
Both men and women are welcome to participate in this research. The study needs to include a diverse group of people to get a full picture of how the medicine affects different individuals.
If you have type 1 diabetes, you might be eligible, or if you are a healthy individual, you could also be considered. Specific health checks will be done by the study team to make sure it's safe for you to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have type 1 diabetes, or are you a healthy adult?
- Are you able to commit to several clinic visits?
- Are you comfortable with blood tests and other medical checks?
What does participation involve?
If you decide to take part, you'll be given the new medicine, NNC0363-1063. This will involve regular visits to the study clinic where doctors and nurses will closely monitor your health. They'll likely take blood samples, check your blood pressure, and perform other tests to see how you're responding to the medicine and to check for any side effects.
The study will have a specific schedule of visits and assessments. You might need to stay at the clinic for certain periods, or have several short visits. You will be told exactly how long the study will last for you, and what is expected at each visit, including how many times you will receive the medicine and for how long. There will also be follow-up appointments after you stop taking the medicine to make sure you are well.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What is 'Phase 1' of a clinical trial?
Phase 1 means this is the first time the new medicine is being given to people. The main goals are to check if it's safe and how it acts in the body.
Will I get the actual medicine or a dummy pill?
In this early phase, all participants usually receive the new medicine. The study doctors will give you full details on this.
What kind of tests will I have if I join?
You will likely have blood tests, blood pressure checks, and other medical examinations to monitor your health and how your body reacts to the medicine.
How long will I be involved in the study?
The exact duration will be explained by the study team, as it varies. It could involve several visits over a few weeks or months, including follow-up appointments.
Will I be paid for taking part?
Some studies offer payment for your time and travel, but others do not. You should ask the study team about this if you are interested.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.